Testing cerebrolysin for brain bleeding
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a drug called cerebrolysin can help people who have a bleeding stroke in the outer part of the brain (lobar hemorrhage). It looks at safety and how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a stroke less than 6 hours ago caused by bleeding in the outer part of the brain (lobar hemorrhage).
- The bleeding is between 30 and 80 milliliters in volume.
- You had no major disability before the stroke (able to live independently).
- You have not had a prior stroke.
- You do not have certain serious medical conditions like kidney or liver failure, a clotting disorder, or active bleeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether Cerebrolysin can improve recovery in people who remain in a vegetative or minimally conscious state more than 4 weeks after a bleeding stroke. It also tracks safety, to make sure the treatment is not causing harmful side effects.
This trial tests a clot-busting drug called tenecteplase to see if it can safely treat a large brain bleed (intracerebral hemorrhage). It may help people who had a bleed within the last 24 hours and whose CT scans show the bleed has stopped growing.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This trial tests whether stem cells can help people recover from a recent, moderate-sized brain bleed (intracerebral hemorrhage). The stem cells are given to reduce damage and improve healing during the first days after the bleed. It may be an option if you had a stroke from a bleed 3 to 10 days ago and you otherwise are in stable health.
This trial tests whether removing a certain type of brain bleed (intracerebral hemorrhage) very early, using a minimally invasive surgery approach, improves outcomes compared with standard treatment. It may help people whose bleed is large enough and who can have surgery within a strict time window.
This trial tests a procedure that uses a small camera to remove the blood clot from the brain, combined with a steroid medication, to reduce damage from a brain bleed. It may be an option for people with a moderate-to-large brain bleed in the outer part of the brain who can be treated within 24 hours.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.